- Home
- SST vs SCNX Comparison
SST vs SCNX Comparison
Compare SST & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SST | SCNX |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.8M | 16.2M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SST | SCNX |
|---|---|---|
| Price | $1.70 | $3.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 55.6K | 49.6K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $266,129,000.00 | $3,831,778.00 |
| Revenue This Year | N/A | $743.36 |
| Revenue Next Year | $21.02 | $325.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $1.35 | $2.64 |
| 52 Week High | $6.05 | $106.25 |
Technical Indicators
Market Signals| Indicator | SST | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 30.68 | 47.07 |
| Support Level | $1.68 | $2.64 |
| Resistance Level | $2.09 | $10.60 |
| Average True Range (ATR) | 0.19 | 0.32 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 8.41 | 49.61 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.